ARch Biopartners Inc (QB) News - ACHFF | Aktien OTCMarkets

Professionelle Tools für Privatanleger.

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

TORONTO, Canada -- November 5, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX...

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

TORONTO, Ontario, CANADA -- October 16, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the...

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

TORONTO, Canada -- June 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture:...

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

TORONTO, Canada -- May 8, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture:...

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

TORONTO, Canada -- April 24, 2020 -- InvestorsHub NewsWire -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ARch Biopartners Inc (QB) (ACHFF)

Professionelle Tools für Privatanleger.

ACHFF Nachrichten

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

ACHFF Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

ARch Biopartners Inc (QB) (ACHFF) News

ARch Biopartners Inc (QB) (ACHFF)

Professionelle Tools für Privatanleger.

ACHFF Nachrichten

Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19

First Patient Dosed in Phase II Trial to Treat Complications in COVID-19

Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.

Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial

Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation

ACHFF Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen